{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T04:19:14Z","timestamp":1778300354571,"version":"3.51.4"},"reference-count":52,"publisher":"Institute of Physiology of the Czech Academy of Sciences","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Physiol Res"],"published-print":{"date-parts":[[2014,8,31]]},"abstract":"<jats:p>Acute liver failure (ALF) is a clinical condition with very high mortality rate. Its pathophysiological background is still poorly understood, which necessitates a search for optimal experimental ALF models with features resembling those of the human disorder. Taking into consideration reproducibility of induction of ALF, adequate animal size, cost of animals, the required time gap between insult and death of animals (\u201ctherapeutic window\u201d), potential risk to investigator and other aspects, administration of thioacetamide (TAA) in rats is currently most recommended. However, the fundamental details of this ALF model have not yet been evaluated. This prompted us to investigate, first, the course of ALF as induced by intraperitoneal TAA at doses increasing from 175 to 700 mg\/kg BW per day. The animals\u2019 survival rate, plasma alanine and aspartate aminotransferase activities, and bilirubin and ammonia levels were determined over the follow-up period. Second, we examined whether Wistar and Lewis rats exhibit any differences in the course of ALF induced by different TAA doses. We found that the optimal dose for ALF induction in rats is 350 mg.kg-1 i.p., given as a single injection. Wistar rats proved more susceptible to the development of TAA-induced ALF compared with Lewis rats. Collectively, our present findings provide a sound methodological background for experimental studies aimed at evaluation of pathophysiology and development of new approaches in the therapy of ALF.<\/jats:p>","DOI":"10.33549\/physiolres.932690","type":"journal-article","created":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T13:56:23Z","timestamp":1604411783000},"page":"491-503","source":"Crossref","is-referenced-by-count":23,"title":["Acute Liver Failure Induced by Thioacetamide: Selection of Optimal Dosage in Wistar and Lewis Rats"],"prefix":"10.33549","author":[{"given":"E.","family":"KOBLIHOV\u00c1","sequence":"first","affiliation":[{"name":"Department of Surgery, Second Faculty of Medicine, Charles University and Central Military Hospital, Prague, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"MR\u00c1ZOV\u00c1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"VERNEROV\u00c1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"RYSKA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"19169","published-online":{"date-parts":[[2014,8,17]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"ANBARASU C, RAJKOPOOR B, BHAT KS, GIRIDHARAN J, ARUL AMUTHAN A, SATISH K: Protective effect of Pisonia aculeate on thioacetamide induced hepatotoxicity in rats. Asian Pac J Trop Biomed 2: 511-515, 2012.","DOI":"10.1016\/s2221-1691(12)60087-2"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"BAN\u0303ARES R, CATALINA MV, VAQUERO J: Liver support systems: will they reach prime time? Curr Gastroenterol Rep 15: 312-319, 2013.","DOI":"10.1007\/s11894-013-0312-x"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"BASILE AS, PANNELL LP, JAOUNI T, GAMMAL SH, FALES HM, JONES EA, SKOLNICK P: Brain concentrations of benzodiazepines are elevated in an animal model of hepatic encephalopathy. Proc Natl Acad Sci 87: 5263-5267, 1990.","DOI":"10.1073\/pnas.87.14.5263"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"BAUDOUIN SV, HOWDLE P, O\u00b4GRADY JG, WEBSTER NR: Acute lung injury in fulminant hepatic failure following paracetamol poisoning. Thorax 50: 399-402, 1995.","DOI":"10.1136\/thx.50.4.399"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"BAUTISTA M, DEL RIO MAG, BENED\u00cd J, S\u00c1NCHEZ-REUS MI, MORALES-GONZ\u00c1LEZ JA, T\u00c9LLEZ-L\u00d3PEZ AM, L\u00d3PEZ-OROZCO M: Effect of dichloromethylene diphsphonate on liver regeneration following thioacetamide-induced necrosis in rats. World J Hepatol 27: 379-386, 2013.","DOI":"10.4254\/wjh.v5.i7.379"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"BERG CL, MERION RM, SHEARON TH, OLTHOFF KM, BROWN RS JR, BAKER TB, EVERSON GT, HONG JC, TERRAULT N, HAYASHI PH, FISHER RA, EVERHART JE: Liver transplant recipient survival benefit with living donation in the model for end-stage liver disease allocation era. Hepatology 54: 1313-1321, 2011.","DOI":"10.1002\/hep.24494"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"BERNAL W, WENDON J: Acute liver failure. N Engl J Med 369: 2525-2534, 2013.","DOI":"10.1056\/nejmra1208937"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"BIDANI AK, POLICHNOWSKI AJ, LOUTZENHISER R, GRIFFIN KA: Renal microvascular dysfunction, hypertension and CKD progression. Curr Opin Nephrol Hypertens 22: 1-9, 2013.","DOI":"10.1097\/mnh.0b013e32835b36c1"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"BONAVITA AG, QUARESMA K, COTTA-DE-ALMEIDA V, PINTO MA, SARAIVA RM, ALVES LA: Hepatocyte xenotransplantation for treating liver disease. Xenotransplantation 17: 181-187, 2010.","DOI":"10.1111\/j.1399-3089.2010.00588.x"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"BUTTERWORTH RF, NORENBERG MD, FELIPO V, FERENCI P, ALBRECTH J, BLEI AT: Experimental models of hepatic encephalopathy: ISHEN guidelines. Liver Int 29: 783-788, 2009.","DOI":"10.1111\/j.1478-3231.2009.02034.x"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"CELIK T, UZBAY IT, CINAR K, BOZKAYA H, UZUNALIMOGLU O, YURDAYDM C: Combination treatment of hepatic encephalopathy due to thioacetamide-induced fulminant hepatic failure in the rat with benzodiazepine and opioid receptor antagonists. J Hepatol 31: 880-886, 1999.","DOI":"10.1016\/s0168-8278(99)80290-6"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"\u010cERT\u00cdKOV\u00c1 CH\u00c1BOV\u00c1 V, VERNEROV\u00c1 Z, KUJAL P, HUSKOV\u00c1 Z, \u0160KAROUPKOV\u00c1 P, TESA\u0158 V, KRAMER HJ, KOMPANOVSKA-JEZIERSKA E, WALKOWSKA A, SADOWSKI J, \u010cERVENKA L, VAN\u011a\u010cKOV\u00c1 I: Addition of ETA receptor blockade increases renoprotection provided by renin-angiotensin system blockade in 5\/6 nephrectomized Ren-2 transgenic rats. Life Sci: in press 2014.","DOI":"10.1016\/j.lfs.2013.12.018"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"CHADIPIRALLA K, REDDANNA P, CHINTA RM, REDDY PVB: Thioacetamide-induced fulminant hepatic failure induces cerebral mitochondrial dysfunction by altering the electron transport chain complexes. Neurochem Res 37: 59-68, 2012.","DOI":"10.1007\/s11064-011-0583-2"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"EGUIA L, MATERSON BJ: Acetaminophen-related acute renal failure without fulminant liver failure. Pharmacotherapy 17: 363-370, 1997.","DOI":"10.1002\/j.1875-9114.1997.tb03721.x"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"FARJAM M, DEHDAB P, ABBASSNIA F, MEHRABANI D, TANIDEH N, PAKBAZ S, IMANIEH MH: Thioacetamide-induced acute hepatic encephalopathy in rat: behavioral, biochemical and histological changes. Iran Red Crescent Med J 14: 164-170, 2012.","DOI":"10.1007\/s00580-014-1883-0"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"HUBNER G: Ultrastructural liver damage caused by direct action of carbon tetrachloride in vivo and in vitro. Virchows Arch Pathol Anat Physiol Klin Med 339: 187-197, 1965.","DOI":"10.1007\/BF00962883"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"ISHAK K, BAPTISTA A, BIANCHI L, CALLEA F, DE GROOTE J, GUDAT F, DENK H, DESMET V, KORB G, MACSWEEN RNM, PHILLIPS MJ, PORTAMNN BG, POULSEN H, SCHEUER PJ, SCHMID M, THALER H: Histological grading and staging of chronic hepatitis. J Hepatol 22: 696-699, 1995.","DOI":"10.1016\/0168-8278(95)80226-6"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"JAESCHKE H, WILIAMS CD, MCGILL MR, XIE Y, RAMACHANDRAN A: Models of drug-induced liver injury for evaluation of phytotherapeutics and other natural products. Food Chem Toxicol 55: 279-289, 2013.","DOI":"10.1016\/j.fct.2012.12.063"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"KUJAL P, \u010cERT\u00cdKOV\u00c1 CH\u00c1BOV\u00c1 V, \u0160KAROUPKOV\u00c1 P, HUSKOV\u00c1 Z, VERNEROV\u00c1 Z, KRAMER HJ, WALKOWSKA A, KOMPANOWSKA-JEZIERSKA E, SADOWSKI J, KITADA K, NISHIYAMA A, HWANG SH, HAMMOCK BD, IMIG JD, \u010cERVENKA L: Inhibition of soluble epoxide hydrolase is renoprotective in 5\/6 nephrectomized Ren-2 transgenic hypertensive rats. Clin Exp Pharmacol Physiol 41: 227-237, 2014.","DOI":"10.1111\/1440-1681.12204"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"KAWAHARA T, TOSO C, DOUGLAS DN, NOURBAKHSH M, LEWIS JT, TYRRELL DL, LUND GA, CHURCHILL TA, KNETEMAN NM: Factors affecting hepatocyte isolation, engrafment, and replication in an in vivo model. Liver Transpl 16: 974-982, 2010.","DOI":"10.1002\/lt.22099"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"KEPLER D, LESCH R, REUTTER W, DECKER K: Experimental hepatitis induced by D-galactosamine. Exp Mol Pathol 9: 279-290, 1968.","DOI":"10.1016\/0014-4800(68)90042-7"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"KIM WR, THERNEAU TM, BENSON JT, KREMERS WK, ROSEN CB, GORES GJ, DICKSON ER: Deaths on the liver transplant waiting list: an analysis of competing risks. Hepatology 43: 345-351, 2006.","DOI":"10.1002\/hep.21025"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"KIM HJ, LARSON JJ, LIM YS, KIM WR, PEDERSEN RA, THERNEAU TM, ROSEN CB: Impact of MELD on Waitlist outcome of retransplant candidates. Am J Transplant 10: 2652-2657, 2010.","DOI":"10.1111\/j.1600-6143.2010.03315.x"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"KOEN YM, SARMA D, HAJOVSKY H, GALEVA NA, WILIAMS TD, STAUDINGER JL, HANZLIK RP: Protein targets of thioacetamide metabolites in rat hepatocytes. Chem Res Toxicol 26: 564-574, 2013.","DOI":"10.1021\/tx400001x"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"LARSON AM: Acetaminophen hepatoxicity. Clin Liver Dis 11: 525-548, 2007.","DOI":"10.1016\/j.cld.2007.06.006"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"LEE WM: Acute liver failure. Semin Respir Crit Care Med 33: 36-45, 2012.","DOI":"10.1055\/s-0032-1301733"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"LEIST M, GANTNER F, KUNSTLE G, BOHLINGER I, TIEGS G, BLUETHMANN H, WENDEL A: The 55-kD tumor necrosis factor receptor and CD95 independently signal murine hepatocyte apoptosis and subsequent liver failure. Mol Med 2: 109-124, 1996.","DOI":"10.1007\/bf03402207"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"MEHENDALE HM: Tissue repair: an important determinant of final outcome of toxicant-induced injury. Toxicol Pathol 33: 41-51, 2005.","DOI":"10.1080\/01926230590881808"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"MUSTAFA HN, AWDAN SAE, HEGAZY GA: Protective role of antioxidants on thioacetamide-induced acute hepatic encephalopathy: biochemical and ultrastructural study. Tissue Cell 45: 350-362, 2013.","DOI":"10.1016\/j.tice.2013.06.001"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"NEWSOME PN, PLEVRIS JN, NELSON LJ, HAYES PC: Animal models of fulminant hepatic failure: a critical evaluation. Liver Transpl 6: 21-31, 2000.","DOI":"10.1002\/lt.500060110"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"NIBOURG GAA, CHAMULEAU RAFM, VAN DER HOEVEN TV, MAAS MAW, RUITER AFC, LAMERS WH, ELFERINK RPJO, VAN GULIK TM, HOEKSTRA R: Liver progenitor cell line hepaRG differentiated in a bioarteficial liver effectively supplies liver support to rats with acute liver failure. PLos ONE 7: e38778, 2012.","DOI":"10.1371\/journal.pone.0038778"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"NISSAR AU, FARRUKH MR, KAISER PJ, RAFIG RA, AFNAN Q, BHUSHAN S, ADIL HS, SUBHASH BC, TASDUG SA: Effect of N-acetylcysteine, an organosulfur compound from Allium plants, on experimentally induced hepatic prefibrogenic events in Wistar rat. Phytomedicine 20: 828-833, 2013.","DOI":"10.1016\/j.phymed.2013.03.009"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"PANTOFLICEK T, KOBLIHOVA E, RYSKA M: S-adenosylmethionine does not reduce ischemia-reperfusion injury to a marginal liver graft in an in vivo experiment. Hepatogastroenterology 59: 216-218, 2012.","DOI":"10.5754\/hge11239"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"PAWA S, ALI S: Liver necrosis and fulminant hepatic failure in rats: protection by oxyanionic form of tungsten. Biochim Biophys Acta 1688: 210-222, 2004.","DOI":"10.1016\/j.bbadis.2003.12.004"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"PRAZAK J, LASZICKOVA E, PANTOFLICEK T, RYSKA O, KOBLIHOVA E, RYSKA M: Cerebral microdialysis reflects the neuroprotective effect of fractional plasma separation and adsorption in acute liver failure better and earlier than intracranial pressure: a controlled study in pigs. BMC Gastroenterol 13: 98, 2013.","DOI":"10.1186\/1471-230x-13-98"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"RAHMAN TM, HODGSON HJF: Animal models of acute hepatic failure. Int J Exp Path 81: 145-157, 2000.","DOI":"10.1046\/j.1365-2613.2000.00144.x"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"RAHMAN TM, DIAKANOV I, SELDEN C, HODGSON H: Co-transplantation of encapsulated HepG2 and rat Sertoli cells improves outcome in a thioacetamide induced rat model of acute hepatic failure. Transpl Int 18: 1001-1009, 2005.","DOI":"10.1111\/j.1432-2277.2005.00156.x"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"RYSKA M, LASZIKOVA E, PANTOFLICEK T, RYSKA O, PRAZAK J, KOBLIHOVA E: Fractionated plasma separation and adsorption significantly decreases intracranial pressure in acute liver failure: experimental study. Eur Surg Res 42: 230-235, 2009.","DOI":"10.1159\/000208790"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"RYSKA O, PANTOFLICEK T, LASZIKOVA E, PRAZAK J, KOBLIHOVA E, RYSKA M: Arterficial liver support system reduces intracranial pressure more effectively than bioarteficial system: an experimental study. Int J Artl Organs 35: 503-510, 2012.","DOI":"10.5301\/ijao.5000099"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"SHI Z, WAKIL AE, ROCKEY DC: Strain-specific differences in mouse hepatic would healing are mediated by divergent T helper cytokine response. Proc Natl Acad Sci USA 94: 10663-10668, 1997.","DOI":"10.1073\/pnas.94.20.10663"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"TANIGUCHI M, TAKEUCHI T, NAKATSUKA R, WATANABE T, SATO K: Molecular process in acute liver injury and regeneration induced by carbon tetrachloride. Life Sci 75: 1539-1549, 2004.","DOI":"10.1016\/j.lfs.2004.02.030"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"TERBLANCHE J, HICKMAN R: Animals models of fulminant hepatic failure. Dig Dis Sci 36: 770-774, 1991.","DOI":"10.1007\/bf01311235"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"TRITTO G, DAVIES NA, JALAN R: Liver replacement therapy. Semin Respir Crit Care Med 33: 70-79, 2012.","DOI":"10.1055\/s-0032-1301736"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"TUN\u0303\u00d3N MJ, ALVAREZ M, CULEBRAS JM, GONZ\u00c1LES-GALLEGO J: An overview of animal models for investigating the pathogenesis and therapeutical strategies in acute hepatic failure. Word J Gastroenterol 15: 3086-3098, 2009.","DOI":"10.3748\/wjg.15.3086"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"YU Y, FISCHER JE, LILLEGARD JB, RODYSIL B, AMIOT B, NYBERG SL: Cell therapies for liver diseases. Liver Transpl 18: 9-21, 2012.","DOI":"10.1002\/lt.22467"},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"VAN\u011a\u010cKOV\u00c1 I, KUJAL P, HUSKOV\u00c1 Z, VA\u0147OURKOV\u00c1 Z, VERNEROV\u00c1 Z, \u010cERT\u00cdKOV\u00c1 CH\u00c1BOV\u00c1 V, \u0160KAROUPKOV\u00c1 P, KRAMER HJ, TESA\u0158 V, \u010cERVENKA L: Effects of combined endothelin A receptor and renin-angiotensin system blockade on the course of end-organ damage in 5\/6 nephrectomized Ren-2 hypertensive rats. Kidney Blood Press Res 35: 382-392, 2012.","DOI":"10.1159\/000336823"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"WEBER LW, BOLL M, STAMPFL A: Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model. Crit Rev Toxicol 33: 105-136, 2003.","DOI":"10.1080\/713611034"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"WILLIAMS CD, BAJT ML, SHARPE MR, MCGILL MR, FARHOOD A, JAESCHKE H: Neutrophil activation during acetaminophen hepatotoxicity and repair in mice and humans. Toxicol Appl Pharmacol 275: 122-133, 2014.","DOI":"10.1016\/j.taap.2014.01.004"},{"key":"ref48","doi-asserted-by":"publisher","unstructured":"WLODZIMIROW KA, ESLAMI S, CHAMULEAU RAFM, NIEUWOUDT M, ABU-HANNA A: Prediction of poor outcome in patients with acute liver failure \u2013 systematic review of prediction models. PLos ONE 7: e50592, 2012.","DOI":"10.1371\/journal.pone.0050952"},{"key":"ref49","doi-asserted-by":"publisher","unstructured":"WU Z, HAN M, CHEN T, YAN W, NING Q: Acute liver failure: mechanisms of immune-mediated liver injury. Liver Int 30: 782-794, 2010.","DOI":"10.1111\/j.1478-3231.2010.02262.x"},{"key":"ref50","doi-asserted-by":"publisher","unstructured":"ZICHA J, KUNES J: Ontogenetic aspects of hypertension development: analyses in the rat. Physiol Rev 79: 1227-1282, 1999.","DOI":"10.1152\/physrev.1999.79.4.1227"},{"key":"ref51","doi-asserted-by":"publisher","unstructured":"ZICHA J, DOBE\u0160OV\u00c1 Z, VOKURKOV\u00c1 M, RAUCHOV\u00c1 H, HOJN\u00c1 S, KADLECOV\u00c1 M, BEHULIAK M, VAN\u011a\u010cKOV\u00c1 I, KUNE\u0160 J: Age-dependent salt hypertension in Dahl rats: fifty years of research. Physiol Res 61 (Suppl 1): S35-S87, 2012.","DOI":"10.33549\/physiolres.932363"}],"container-title":["Physiological Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T21:15:07Z","timestamp":1723842907000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.biomed.cas.cz\/physiolres\/pdf\/63\/63_491.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,17]]},"references-count":52,"URL":"https:\/\/doi.org\/10.33549\/physiolres.932690","relation":{},"ISSN":["1802-9973","0862-8408"],"issn-type":[{"value":"1802-9973","type":"electronic"},{"value":"0862-8408","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8,17]]}}}